A practical reference on counterion: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-09-27. Anything still debated is marked as such rather than presented as settled.
Impurity profiling identifies and quantifies substances that coexist with the target peptide. These include deletion sequences, truncated peptides, oxidized variants, and residual protecting groups from synthesis. Reversed-phase chromatography can separate many of these impurities, but co-elution remains a challenge for closely related species. Mass spectrometry helps assign identities to impurity peaks, and impurity limits are often set as area percentages relative to the main peak. Regulatory guidelines for research-grade peptides are less strict than those for therapeutic products, so specifications vary by supplier.
Quality control for peptides involves setting specifications for identity, purity, and counterion content. Batches are tested against these specifications before release. Purity specifications often require a minimum area percentage by high-performance liquid chromatography, such as 95% or 98%, depending on the intended application. Additional tests may include water content, acetate or trifluoroacetate content, and residual solvents. These parameters affect the net peptide content and the accuracy of subsequent laboratory experiments.
Stability testing examines how peptide purity changes over time under defined conditions. Accelerated studies use elevated temperatures and humidity to predict degradation pathways, while long-term studies store samples at recommended temperatures. Common degradation reactions include oxidation of methionine, deamidation of asparagine, and hydrolysis of peptide bonds. The results inform expiration dates and storage recommendations for research materials. Lyophilized peptides are generally more stable than solutions, but both forms can degrade if exposed to moisture, oxygen, or repeated freeze-thaw cycles.
Handling practices strongly affect measured purity and sample integrity. Many peptides are hygroscopic, susceptible to oxidation, or prone to adsorption on glass and plastic surfaces. Lyophilized powders are typically stored desiccated at -20 °C or below, while solutions may require colder storage and minimized freeze-thaw cycles. Peptides containing cysteine, methionine, or tryptophan can degrade through oxidation or disulfide exchange. Working aliquots reduce repeated exposure to moisture and temperature fluctuations during routine analysis.
Purity values do not necessarily predict biological potency. Net peptide content corrects for counterions such as acetate or trifluoroacetate, water, and residual salts. Impurity thresholds for reporting, identification, and qualification are often set according to regulatory guidance, though specific limits depend on the product class and route of administration. Open questions remain about the toxicological relevance of low-level peptide impurities and about how best to compare results across different analytical platforms. A certificate of analysis should state the methods used and the basis for each reported value.
Peptide purity testing sits within a broader quality control framework. Release testing commonly includes appearance, identity, purity, peptide content, counterion content, water content, and residual solvents. Elemental impurities and microbiological attributes may be examined when relevant to the manufacturing route. Pharmacopoeial monographs and general chapters provide methods and acceptance criteria for some peptides, but many research-grade materials are not covered by such standards. Method validation establishes specificity, linearity, accuracy, precision, range, and robustness for each test.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature (lyophilized) | -20 °C | Long-term storage; -80 °C for extended periods |
| Typical storage temperature (solution) | -80 °C | Avoid repeated freeze-thaw; aliquot before freezing |
| Common degradation pathway | Oxidation of methionine | Affects peptides containing methionine; accelerated by oxygen |
| Common counterion | Trifluoroacetate | From HPLC purification; acetate also common |
| Purity specification (research grade) | ≥95% by HPLC area | Higher grades may require ≥98%; method-dependent |
Reversed-phase high-performance liquid chromatography (RP-HPLC) is widely used to estimate peptide purity. Separation depends on interactions between peptide residues and a hydrophobic stationary phase, with gradients of water and organic solvent. Ultraviolet detection near 214 nm responds to the peptide backbone and to many related impurities. The resulting chromatogram is often expressed as area percent, which reports the proportion of peak area assigned to the main component. Different columns, gradients, and wavelengths can produce different purity values for the same material.
Mass spectrometry provides complementary information about molecular identity and certain impurities. Electrospray ionization and matrix-assisted laser desorption/ionization are common ionization techniques for peptides. A measured mass close to the expected value supports correct sequence length and modifications, while extra mass signals can reveal truncations, adducts, or incomplete deprotection. Mass spectrometry alone is not a quantitative purity assay, because ionization efficiency varies between compounds. Coupling liquid chromatography to mass spectrometry links retention time with mass and helps assign peaks that ultraviolet detection records.
Solid-phase peptide synthesis can produce truncated sequences when coupling reactions fail. Deletion peptides lack one or more internal residues, while truncation peptides end prematurely. Side reactions include aspartimide formation, oxidation of methionine, and aggregation during chain assembly. Crude synthetic peptides therefore contain target peptide plus related impurities, counterions, residual solvents, and water. Purification by preparative chromatography reduces these impurities but does not remove every closely related species, including some that differ by a single amino acid.
Quality control specifications for peptides typically include appearance, identity, purity by RP-HPLC, water content, counterion content, and residual trifluoroacetic acid. Karl Fischer titration measures water, while ion chromatography or elemental analysis can quantify counterions. Purity specifications may be set at 95% or 98% area percent, but the appropriate threshold depends on the application. For research reagents, a lower purity may be acceptable if identity is confirmed. For assays sensitive to impurities, higher purity and orthogonal testing are often required.
Handling and storage influence measured purity, and peptides can oxidize, deamidate, aggregate, or adsorb to surfaces over time. Lyophilized powders stored at -20 °C or lower are generally more stable than solutions, though some sequences require different conditions. Repeated freeze-thaw cycles can promote aggregation and loss, so testing after storage checks whether purity has changed. Stability-indicating methods compare stressed and unstressed samples to detect degradation pathways. Light exposure and pH can also accelerate modification.
Reported purity values can differ between laboratories even for the same sample. Variations arise from column chemistry, mobile-phase composition, gradient slope, detection wavelength, injection load, and integration rules. Area percent also assumes that all species have similar response factors, which is not always true. Method validation examines specificity, linearity, accuracy, precision, limit of detection, and limit of quantitation. When comparing certificates, the method description and representative chromatogram are as important as the headline percentage.
Purity and potency are related but distinct concepts in peptide testing. Purity describes the proportion of the main peptide relative to other detected substances, while potency refers to the biological or functional activity of a defined amount. A highly pure peptide can still have low potency if it is misfolded, aggregated, or chemically modified at a critical residue. Conversely, a less pure preparation may retain high activity if the impurities are inactive. Clear reporting separates these attributes and states the assay used for each.
Interpreting chromatographic purity requires attention to detection limits and response factors. Peptides without aromatic residues may absorb weakly at 280 nm, so 214 nm is often preferred, but mobile-phase additives and solvents also absorb at low wavelengths. Co-eluting impurities with different molar absorptivities can produce area percentages that differ from mass percentages. Integration parameters, peak tailing, and baseline choice further affect reported values. For these reasons, method details belong alongside any purity figure, and orthogonal methods are needed to confirm identity and impurity profiles.
Reverse-phase high-performance liquid chromatography is the most common primary method for peptide purity testing. The peptide mixture passes through a hydrophobic stationary phase, and components elute according to differences in hydrophobicity. A mobile phase of water and acetonitrile, often with trifluoroacetic acid as an ion-pairing agent, improves peak shape and retention. Ultraviolet detection at 214 nm records the peptide backbone absorbance, and the main peak area is divided by the total peak area to give an area-percent purity value.
Other chromatographic modes provide complementary information that reverse-phase separation may not capture. Ion-exchange chromatography separates peptides by net charge and can resolve deamidated, oxidized, or truncated variants that co-elute under hydrophobic conditions. Size-exclusion chromatography detects aggregates and higher-order oligomers, which are often invisible in reverse-phase assays. Chiral chromatography can quantify D-amino acid epimers when stereochemical purity matters. Because each mode uses a different separation principle, a single purity number from one method cannot describe all possible impurities.
Tarlov cysts, also known as perineural cysts, are cerebrospinal fluid (CSF)-filled lesions that most commonly develop in the sacral region of the spinal canal (S1–S5), and less frequently in the cervical, thoracic, or lumbar spine. These cysts form as dilations of the nerve root sheath near the dorsal root ganglion, specifically within the perineural space between the endoneurium and perineurium. A defining feature is that the cyst walls contain nerve fibers, which often line the inner cavity of the cyst itself. This involvement of neural elements distinguishes Tarlov cysts from other extradural meningeal cysts, such as meningeal diverticula, which do not contain nerve fibers. The etiology of these cysts is not well understood; some current theories explaining this phenomenon include increased spinal fluid pressure, filling of congenital cysts with one-way valves, and/or inflammation in response to trauma and disease. They are named after an American neurosurgeon Isadore Tarlov, who described them in 1938. These cysts are often detected during MRI or CT scans. They are also observed using magnetic resonance neurography with communicating subarachnoid cysts of the spinal meninges. Cysts with diameters of 1cm or larger are more likely to be symptomatic; although cysts of any size may be symptomatic dependent on location and etiology. Some 40% of patients with symptomatic Tarlov cysts can associate a history of trauma or childbirth.
== Function == Fibromodulin participates in the assembly of the collagen fibers of the extracellular matrix. It binds to the same site on the collagen type I molecule as lumican. It also inhibits fibrillogenesis of collagen type I and collagen type III in vitro. It regulates TGF-beta activities by sequestering TGF-beta into the extracellular matrix.
The most common method for alkylation of the lactam nitrogen of 2,5-diketopiperazines is based on the use of sodium hydride as base. However epimerisation can occur especially with proline-fused 2,5-diketopiperazines, even with milder methods such as under phase-transfer catalyst conditions for example 1 to 2. Reduction of the carbonyl groups of chiral 2,5-diketopiperazine with lithium aluminium hydride (LiAlH4) cleanly gives the corresponding chiral piperazines. For example, cyclo(L-Phe-L-Phe) 1 gives the chiral piperazine (2S,5S)-dibenzylpiperazine 2. Reaction of the lactam-derived enol phosphates 4 of 2,5-diketopiperazines with palladium catalyzed reactions (reduction, Suzuki and Stille cross-coupling reactions) enables the synthesis of a range of functionalised 1,4-dihydropyrazines 5 which can be aromatized to 1,4-pyrazines 6 in the presence of acid.
== Works cited == "The Best of 2004; The 14th Annual Computer Games Awards". Computer Games Magazine. No. 172. Fort Lauderdale, Florida: theGlobe.com. March 2005. pp. 48–56. "2004 Games of the Year". Computer Gaming World. No. 249. Cambridge, Massachusetts: Ziff Davis. March 2005. pp. 56–67. Retrieved November 3, 2020. Osborn, Chuck (2003). "Cover Story: Bloodlines - The Half Life 2 Engine Gets Dead Sexy". PC Gamer US. Vol. 10, no. 114. United States: Ace St. Germain. pp. 46–54. ISSN 1080-4471. Osborn, Chuck (2005). "Reviews - Vampire: The Masquerade - Bloodlines". PC Gamer US. Vol. 12, no. 132. United States: Ace St. Germain. pp. 92–94. ISSN 1080-4471.
Sources: en.wikipedia.org
In April 2012, the Xinjiang Border Defense Corps Female Special Service team (新疆公安边防总队女子特勤分队) was founded. In March 2015 it was renamed to the "Snowy Eagle Female Special Service team" (雪鹰女子特勤分队) at the Xinjiang Border Corps Training Base. At its founding in 2012, it only had 6 members, and by March 2015 it had 34 members. It assisted in security at the China Eurasia Expo multiple times. The Shenzhen Border Defense Detachment operated the Maritime Special Service Team (Nicknamed "Maritime Jiaolongs"), a police tactical unit which is dedicated to maritime anti-terrorism, search and rescue, combat diving and VBSS.
=== Arjo === Arjo was founded in 1957 by Arne Johansson in the Swedish town of Eslöv. The company name consists of the first two letters of the first and last name of the company founder. Arjo initially functioned as a supplier of components and machine parts to medical device manufacturers. In 1972, the company developed the first height-adjustable bathtub and introduced it to the market. In 1993, the company's shares are listed on the Stockholm Stock Exchange and the London Stock Exchange. In 1995, the company merged with the Swedish Getinge Group, in whose "Extended Care" business area it continued to operate under its brand name. In 2004, Arjo took over the company BHM Medical and rounded off its range of passenger lifts with its Ceiling Lifts.
Enterotoxins are potent compounds produced by various microorganisms that specifically target and damage the intestines, causing many of the most rapid and severe forms of food poisoning. Unlike bacterial infections that require live organisms to multiply in the gut, enterotoxins (a type of exotoxin) can cause illness even when the bacteria that produced them have been killed through cooking or other preservation methods. Symptom onset varies with the toxin but may be rapid in onset, as in the case of enterotoxins of Staphylococcus aureus in which symptoms appear in one to six hours. This causes intense vomiting including or not including diarrhea (resulting in staphylococcal enteritis), and staphylococcal enterotoxins (most commonly staphylococcal enterotoxin A but also including staphylococcal enterotoxin B) are the most commonly reported enterotoxins although cases of poisoning are likely underestimated. It occurs mainly in cooked and processed foods due to competition with other biota in raw foods, and humans are the main cause of contamination as a substantial percentage of humans are persistent carriers of S. aureus. The CDC has estimated about 240,000 cases per year in the United States.
Sources: en.wikipedia.org
== Medical use == Thermal pharmaceutical bags are designed to transport temperature-sensitive medications, protecting them from damaging temperatures, shocks, and light. Many vaccines are delicate biological substances that can lose part or all of their effectiveness if they are frozen, allowed to get too hot, or exposed to bright light. Such vaccines must be kept within a specified temperature range, typically 2 to 8 °C (36 to 46 °F), from manufacture to use. According to the World Health Organization, at least 7% of temperature-sensitive medical products suffer significant degradation in potency in transit.
== Background == The summit was held on the French shore of Lake Geneva, close to the border with Switzerland. Because delegations were expected to arrive through Geneva Airport, the event required security coordination between France, Switzerland and the Swiss cantons of Geneva, Vaud and Valais. The summit had initially been announced for 14–16 June 2026, but was later postponed by a day to 15–17 June, to avoid a clash with the planned UFC Freedom 250 mixed martial arts event held on US president Donald Trump's birthday. French president Emmanuel Macron made the reduction of global economic imbalances a priority for France's G7 presidency, citing industrial overcapacity, underinvestment, excessive debt, deregulation and low private investment in developing countries among the threats to economic stability. The summit took place in the aftermath of reports of a memorandum of understanding between the US and Iran aimed at ending the Iran War and reopening the Strait of Hormuz. Trump signed the memorandum at the Palace of Versailles on 17 June 2026, during a dinner hosted by Macron after the summit.
== Awards and honors == In 2020, Flegg was awarded the JH Michell Medal for excellence in research by ANZIAM (Australian and New Zealand Industrial and Applied Mathematics), as well as the Christopher Heyde Medal from the Australian Academy of Science and the Society of Mathematical Biology. In 2025, Flegg was awarded the EO Tuck Medal by the Australian Mathematical Society in recognition of her outstanding research and distinguished service to the field of applied mathematics. She was elected a Fellow of the Australian Academy of Science in 2026.
Sources: en.wikipedia.org
Lyophilized peptides are typically stored at -20 °C or lower, protected from moisture and light. Solutions are often stored at -80 °C and divided into single-use aliquots. Repeated freeze-thaw cycles should be avoided.
Oxidation of methionine and deamidation of asparagine are frequent reactions. Hydrolysis of peptide bonds can occur under acidic or basic conditions. Each pathway produces impurities that reduce purity.
Specifications depend on the intended use and supplier. Common minimums are 95% or 98% by HPLC area percentage. Identity and counterion content are also checked.
Lyophilized peptides are generally stored desiccated at -20 °C or lower, protected from light and moisture. Solutions are often kept at -80 °C in aliquots to limit freeze-thaw damage. Specific sequences may require different conditions based on oxidation or aggregation risk.